• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates
Home » 7 medtech stories we missed this week: April 7, 2017

7 medtech stories we missed this week: April 7, 2017

April 7, 2017 By Danielle Kirsh

[Image from unsplash.com]
New studies for umbilical cord allografts and tumor targeting were published this week while another company received European CE Marking.

Here are some medtech stories we missed this week but thought were still worth mentioning.

1. AMNIOX touts new umbilical cord study

AMNIOX Medical announced that it has published the results of 3 studies that demonstrate the effectiveness of umbilical cord tissue for treating chronic wounds, according to an April 7 press release. The company’s cryopreserved human umbilical cord tissue, NEOX Cord 1K was tested on 29 patients who needed a wound allograft to treat chronic diabetic foot ulcers. Twenty-eight of the 32 wounds showed complete healing with a success rate of 87.5%. In another test, 57 patients with chronic, lower-extremity ulcers received the treatment. Fifty-one out of 64 wounds with a healing rate of 79.7% had complete healing. The third study tested 31 patients who had lower extremity ulcers with exposed bone, tendon, muscle or joint capsule with underlying osteomyelitis. Twenty-six out of 33 wounds had completely healed, resulting in a healing rate of 78%.

2. InVivo Therapeutics enrolls another patient in study

InVivo Therapeutics announced in an April 5 press release that it has enrolled a new patient into its Inspire study that is meant to test the benefits of the Neuro-Spinal Scaffold. The surgery was performed on the patient 42 hours after injury at the Carolinas Medical Center in Charlotte, N.C. The addition of this patient makes the total of enrolled patients 14. The Neuro-Spinal Scaffold is designed to support appositional healing and reduce post-traumatic cavity formation while sparing white matter and allowing for neural regeneration across the healed wound epicenter.

3. Occlutech receives CE Mark

Occlutech has received European CE Mark for its Perimembranous Ventricular Septal Defect (PmVSD) Occluder, according to an April 5 press release. The PmVSD is an implant that is designed for the minimally invasive closure of perimembranous ventricular septal defects. It is made with a flexible nitinol wire mesh with shape memory properties.

4. Cianna Medical announces new data for Scout radar localization system

Cianna Medical announced in an April 6 press release that data from its Scout radar localization system has been proven to be clinically equivalent to radio seed localization for surgical targeting of non-palpable breast lesions. There were 119 patients in the study who went through breast conserving therapy using the Scout radar localization or RSL, which uses a radioactive seed to target tumors. The study showed that the average volume of resection and repeats surgery rates were about equal with successful removal of markers. Scout is a zero-radiation, wire-free solution for breast tumor localization. It is FDA-cleared and is smaller than a grain of rice. Scout uses a highly-sophisticated reflector that is placed at the tumor site 30 days before a lumpectomy or surgical biopsy. The surgeon then scans the breast during the procedure using the Scout guide that emits 50 million pulses per second.

5. AngioDynamics announces pricing of secondary offering

AngioDynamics announced the pricing of its previously announced underwritten public offering by its stockholders in an April 6 press release. It is offering 2.35 million shares of its common stock at a public price of $16.20 per share. The selling stockholders will receive the net proceeds from the offering. The company is not selling shares. Barclays Capital is the sole underwriter of the offering.

6. Nu-Med selects advisors to valuate company

Nu-Med Plus has chosen Houlihan Advisors for an independent company valuation, according to an April 5 press release. Nu-Med Plus has garnered a lot of technical know-how, intellectual property and has developed multiple products as a research and development company. Houlihan Advisors will be providing a current valuation of all of its assets.

7. Aesculap launches novel spine device warranty

Aesculap Implant Systems announced in an April 6 press release that it has created a new warranty program on its established portfolio of surface-enhanced interbodies for spinal fusion. The warranty gives participating facilities a device replacement in the case of a reiteration because of clinically-relevant delamination or the generation of impaction debris or a CT or MRI artifact caused by a device that reduces the physician’s ability to see anatomy. This warranty is the first facility risk-share agreement on titanium-enhanced PEEK interbody in the spine industry.

Here’s what we missed last week.

Filed Under: Clinical Trials, Radiosurgery/Radiation therapy, Regulatory/Compliance, Research & Development, Spine, Wound Care Tagged With: aesculap, Amniox, AngioDynamics, Cianna Medical, InVivo Therapeutics, MedTech, Nu-Med, Occlutech

In case you missed it

  • CeQur is launching a discreet, convenient ‘wearable insulin pen’
  • Teva appoints former Vertex exec as new head of R&D, CMO
  • Enovis partners with Kelvi on hot and cold therapies
  • West Pharmaceutical Services debuts new needle syringe system
  • Titan Medical names Cary G. Vance as new president, CEO
  • Acutus completes first closing in left-heart access portfolio sale to Medtronic
  • FDA clears Intuitive, Siemens Healthineers imaging integration for robotic bronchoscopy
  • FDA backs COVID-19 boosters with BA.4/5 spike proteins for fall
  • How safe is health information after the overturning of Roe?
  • Smith+Nephew opens new plant in Malaysia
  • BD launches combination COVID-19, flu, RSV diagnostic test
  • Zimmer Biomet creates independent nonprofit organization to reduce health disparities
  • Dexcom focuses on early diabetes diagnosis as COVID links emerge
  • Nasdaq grants Titan Medical 180-day extension to regain compliance
  • Aerin Medical reports positive 4-year results for VivAer treatment
  • Blackrock Neurotech and Pitt work on first at-home BCI system for remote trials
  • How medical device companies are responding to abortion bans

RSS From Medical Design & Outsourcing

  • Supply Chain EVP Greg Smith sees fewer suppliers in Medtronic’s future
    All eyes are on Medtronic’s global operations and supply chain leader as he works to modernize its operations and scrutinize suppliers. EVP of Global Operations and Supply Chain Greg Smith anticipates fewer suppliers in Medtronic’s future, he said in an interview this week. Smith spoke with DeviceTalks Editorial Director Tom Salemi in his first published… […]
  • CeQur is launching a discreet, convenient ‘wearable insulin pen’
    CeQur designed its Simplicity device to make insulin delivery as seamless as possible for people with diabetes. When it comes to managing diabetes, CeQur wants to make insulin therapy as convenient as possible. For those who prefer to manage their own insulin delivery, the Simplicity device might just do exactly that. Simplicity, a wearable, disposable… […]
  • Meddux opens new facility in Colorado
    Engineering, design, development and manufacturing company Meddux announced that it opened a new facility in Boulder, Colorado. The new, 22,000-square-foot facility doubles the overall square footage from its previous location in Colorado. According to a news release, it helps the company to quadruple its product development area and double its manufacturing footprint. Meddux’s new facility… […]
  • Reducing the Overall Cost of Validation
    By PTI Engineered Plastics Reliable medical devices and equipment are essential for researchers and doctors to accurately diagnose and treat a wide range of diseases. That is why there is such stringent oversight from the FDA to ensure these products meet the necessary requirements and specifications. To ensure compliance with regulators, manufacturers follow installation qualification… […]
  • BBS Automation has a deal to buy medtech supplier Kahle Automation
    BBS Automation said it plans to purchase high-speed automation supplier Kahle Automation to expand its medtech and life sciences business. Kahle will operate as Kahle – a BBS Company, according to a news release from Munich, Germany-based BBS and Lombardy, Italy-based Kahle. The deal is subject to regulatory approval. Terms were not disclosed. Kahle’s co-owners —… […]
  • How safe is health information after the overturning of Roe?
    The U.S. Department of Health and Human Services today issued guidance meant to better protect women’s health information as state abortion bans kick in after the U.S. Supreme Court’s overturning of Roe v. Wade. Despite the HHS actions, women may still wonder whether their health information is entirely safe going forward — a potential challenge… […]
  • Dexcom focuses on early diabetes diagnosis as COVID links emerge
    New evidence is showing that COVID-19 may increase a person’s risk of diabetes, but it could be years until we know for sure. In the meantime, Dexcom (Nasdaq:DXCM) is getting ready, VP of Global Clinical Initiatives Tomas Walker said. Walker recently spoke with Medical Design & Outsourcing to discuss the San Diego-based diabetes device developer’s… […]
  • Blackrock Neurotech and Pitt work on first at-home BCI system for remote trials
    Blackrock Neurotech and the University of Pittsburgh’s Rehab Neural Engineering Labs (Pitt RNEL) are working together on the first portable brain-computer interface (BCI) to allow patients to participate in research trials from home. A Blackrock representative said it’s the final step as the company prepares to launch its first commercial product early next year. Salt… […]
  • How medical device companies are responding to abortion bans
    Days after the U.S. Supreme Court’s decision to overturn Roe v. Wade’s protection of abortion rights, medical device companies are among those reassuring workers about healthcare access. Corporate communications to employees and the public at large come as trigger laws in nearly half of the states outlaw abortion immediately. Some medtech companies are not using… […]
  • Philips updates on testing results for recalled ventilators
    Royal Philips (NYSE:PHG) says only a small portion of returned respiratory devices displayed the sound abatement foam degradation that sparked a massive recall. Repeated ozone cleaning may have made the problem worse. Those were some of the major takeaways from an update Philips provided today on a comprehensive test and research program it implemented after its… […]
  • ResMed names Lucile Blaise as new Sleep & Respiratory Care leader
    Lucile Blaise will be the new president of ResMed’s Sleep & Respiratory Care business starting July 1, ResMed (NYSE: RMD) said today. She replaces Jim Hollingshead, who became president and CEO of Insulet (Nasdaq:PODD) on June 1. ResMed President and COO Rob Douglas is serving as interim president of the Sleep & Respiratory Care during… […]

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS